Norit 200 (Charcoal, Activated)

Activated charcoal works by providing a highly porous carbon surface that adsorbs molecules through physical forces. When taken orally, it captures toxins, medications, and gases in the gastrointestinal tract, forming complexes that are not absorbed and are expelled in the stool, thereby limiting systemic exposure.

The dose of Norit 200 is individualized and set by a qualified healthcare professional based on factors such as the type and amount of toxin ingested, the time elapsed since exposure, patient age, weight, and clinical condition. No fixed dosing regimen is provided in the product information.

Safety data for activated charcoal in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Use should only be considered when the potential benefit outweighs any possible risk, and it must be prescribed by a clinician familiar with the patient’s condition.

To order Norit 200, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any special handling), and necessary import documentation.

Norit 200, like other activated charcoal preparations, offers broad‑spectrum adsorption of many toxins and drugs, making it a versatile first‑line option. Compared with specific antidotes, it does not neutralize the toxin chemically but reduces absorption. Its safety profile is well established, though it lacks activity against metals such as iron or lithium, which require alternative agents.

Store Norit 200 at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, heat, and direct sunlight to maintain product integrity and prevent clumping of the powdered form.

Norit 200 is administered orally. The powdered form is typically mixed with a small amount of water or another suitable liquid to form a slurry, which the patient drinks promptly. Administration should be performed under medical supervision, especially in emergency settings, to ensure correct technique and dosing.

The most serious risks include aspiration of the charcoal into the lungs, which can cause pneumonia, and bowel obstruction from accumulated charcoal mass. Rarely, severe allergic reactions or significant electrolyte disturbances may occur. Prompt medical evaluation is essential if any of these complications are suspected.

Norit 200 should be avoided in patients with a compromised airway who are not protected by intubation, in individuals who have ingested substances such as iron, lithium, or cyanide salts, and in those with known hypersensitivity to activated charcoal. It is also contraindicated when there is a risk of gastrointestinal perforation.